Mapping Protein–Protein Interactions by Mass Spectrometry: A Comprehensive Guide to Modern Interactomics

Introduction

Protein–protein interactions (PPIs) form the molecular backbone of all cellular processes. From signal transduction and chromatin remodeling to immune responses and metabolic regulation, proteins rarely act alone. Instead, they assemble into dynamic, context-dependent complexes that define cellular function.

Deciphering these interaction networks collectively known as the interactome is essential for understanding both normal physiology and disease mechanisms. Over the past two decades, mass spectrometry (MS)-based proteomics has emerged as the most powerful and versatile platform for large-scale PPI mapping.

Unlike traditional binary interaction assays, MS-based approaches enable system-wide, unbiased, and quantitative characterization of protein complexes in their native cellular environments.

---

The Biological Importance of Protein–Protein Interactions

Protein interactions can be classified into several categories:

Stable Interactions

Found in multi-subunit complexes (e.g., ribosomes, proteasomes)

Long-lived and structurally defined

Transient Interactions

Occur during signaling cascades

Weak and short-lived

Conditional Interactions

Depend on cellular states (e.g., phosphorylation, stress, ligand binding)

Disruption of PPIs is a hallmark of many diseases:

Cancer: aberrant signaling complexes

Neurodegeneration: protein aggregation and misfolding

Infectious diseases: host–pathogen interaction hijacking

Thus, mapping PPIs is not only descriptive but also mechanistically and therapeutically critical.

---

Why Mass Spectrometry Dominates PPI Analysis

Mass spectrometry offers a unique combination of features:

✔ Sensitivity & Dynamic Range

Modern MS instruments detect proteins across several orders of magnitude in abundance

✔ Specificity

Peptide-level identification ensures precise protein assignment

✔ Throughput

Thousands of proteins can be analyzed in a single experiment

✔ Quantitative Capability

Label-free or isotope labeling approaches allow interaction strength measurement

✔ Structural Insight

When combined with cross-linking, MS provides spatial constraints

These advantages position MS as the central technology in interactomics.

---

Core Mass Spectrometry-Based PPI Mapping Strategies

FIGURE 1 MS‐based approaches to studying interactomes. (A) Affinity tags are used in affinity purification (AP). Protein of interest (POI) that
has been affinity tagged can be produced transiently or stably in selected cell lines. Subsequently, matrix conjugated to antiaffinity tag antibodies are
added so that the tag fused POI and its interactors can be selectively enriched. (B) Cross‐linking can be done in vitro after purifying protein complexes
or in vivo with intact cells. The cross‐linked proteins are digested to produce cross‐linked peptides, which are then enriched before mass spectrometry
(MS) analysis. (C) The proximity labeling (PL) procedure. An enzyme is genetically fused to the POI and expressed in the cell line of choice. In vivo
labeling is accomplished by introducing substrate into the cells, which converts these molecules into reactive intermediates for PL. Labelled proteins
can be enriched. (D) Combination of AP and PL. Depending on the culture state and lysis buffer combination, MAC‐tagged POI can be utilized for
both AP and PL procedures. The same matrix is used to enrich protein complexes. (E) In bottom‐up proteomics, peptides derived from proteolytic
digestion are first desalted to remove salts that can interfere with subsequent analyses. The cleaned peptide mixture is then loaded onto an liquid
chromatography column for liquid chromatography, followed by electrospray ionization. Ionized peptides are analyzed using two primary MS
strategies: data‐dependent acquisition (DDA), where ions are scanned and the most abundant peptides are chosen for MS/MS scans, and data‐
independent acquisition (DIA), where all peptides within a set mass range are systematically fragmented. These approaches yield tandem mass
spectra for peptide identification and inference of associated proteins. (F) Data analysis begins with the comparison of experimental spectra against a
theoretical database to establish peptide–protein matches, which then form an interaction matrix. Interaction probabilities are statistically scored to
recognize high‐confidence interactions (HCIs). These HCIs, extracted from filtering processes, are used to construct a protein–protein interaction
network, elucidating the intricate web of protein interactions within the cellular environment.

1. Affinity Purification–Mass Spectrometry (AP-MS)

Principle

A “bait” protein is isolated along with its interacting partners (“prey”) using affinity-based methods. The purified complex is then analyzed via LC-MS/MS.

Experimental Workflow

1. Genetic tagging (e.g., FLAG, HA, GFP) or antibody-based capture

2. Cell lysis under native conditions

3. Affinity purification

4. Stringent washing to remove non-specific binders

5. Enzymatic digestion (trypsin)

6. LC-MS/MS identification

Strengths

High specificity

Suitable for stable complexes

Scalable for proteome-wide studies

Limitations

Loss of transient/weak interactions

Potential artifacts from overexpression

Advanced Variants

Tandem affinity purification (TAP)

Quantitative AP-MS (using SILAC or TMT)

---

2.  Proximity Labeling Approaches

These methods overcome AP-MS limitations by capturing proteins in close spatial proximity rather than requiring stable binding.

Key Technologies

BioID (biotin ligase-based labeling)

APEX (engineered peroxidase labeling)

Mechanism

1. Bait protein fused to an enzyme

2. Enzyme generates reactive labeling species

3. Nearby proteins are covalently tagged (e.g., biotinylated)

4. Labeled proteins are purified and identified by MS

Advantages

Captures transient and weak interactions

Works in live cells

Spatially resolved interactomes

Limitations

Labeling radius may include false positives

Requires careful controls

---

3.  Cross-Linking Mass Spectrometry (XL-MS)

Concept

Chemical cross-linkers covalently connect interacting amino acid residues, preserving protein interactions during analysis.

Workflow

1. Apply cross-linking reagent (e.g., DSS, BS3)

2. Digest proteins into peptides

3. Enrich cross-linked peptides

4. Analyze via high-resolution MS

Unique Advantages

Provides distance constraints (structural insight)

Maps interaction interfaces

Useful for modeling protein complexes

Challenges

Complex data analysis

Low abundance of cross-linked peptides

---

4.  Co-Fractionation Mass Spectrometry (CoFrac-MS)

Principle

Protein complexes are separated by biochemical fractionation:

Size exclusion chromatography

Ion exchange

Density gradients

Proteins that co-elute across fractions are inferred to interact.

Strengths

No genetic manipulation required

Suitable for endogenous complexes

Scalable to proteome-wide mapping

Weaknesses

Indirect inference of interactions

Requires computational modeling

---

 Quantitative Proteomics in PPI Analysis

Quantification is essential for distinguishing true interactors from background.

Common Approaches

Label-Free Quantification (LFQ)

Based on peptide intensity

Simple but sensitive to variability

SILAC (Stable Isotope Labeling)

Incorporates heavy amino acids in vivo

High accuracy for comparative studies

Tandem Mass Tags (TMT)

Multiplexing capability

High throughput

Quantitative data enables:

Interaction strength measurement

Dynamic interaction studies

Condition-specific interactome analysis

---

Computational Analysis of PPI Data

MS-based PPI datasets are large and complex, requiring advanced bioinformatics:

Key Steps

1. Peptide identification (search engines like Mascot, Sequest)

2. Protein inference

3. Contaminant filtering

4. Statistical scoring (e.g., SAINT, MiST)

5. Network reconstruction

Challenges

False positives from non-specific binding

Batch effects

Missing data

Visualization Tools

Cytoscape

STRING database integration

---

 Experimental Design Considerations

To ensure high-quality PPI data:

Controls

Negative controls (empty tag)

Mock purifications

 Replicates

Biological and technical replicates improve confidence

Stringency

Optimize washing conditions to reduce background

Tag Selection

Avoid interfering with protein function

---

 Applications of MS-Based Interactomics

 Systems Biology

Reconstruction of protein interaction networks

Identification of functional modules

 Drug Discovery

Targeting protein interaction interfaces

Identification of druggable complexes

 Disease Mechanisms

Mapping altered interactomes in cancer

Studying neurodegenerative protein aggregation

 Host–Pathogen Interactions

Understanding viral hijacking of host machinery

Identifying therapeutic targets

---

Emerging Trends in Interactomics

 Single-Cell Proteomics

Enables PPI analysis at cellular resolution

Critical for heterogeneous tissues

 Multi-Omics Integration

Combining:

Proteomics

Transcriptomics

Genomics

→ Provides a holistic view of cellular systems

---

Improved Instrumentation

Higher resolution MS

Faster acquisition speeds

Enhanced sensitivity

---

Conclusion

Mass spectrometry has fundamentally transformed the study of protein–protein interactions, enabling researchers to move from single interactions to complex, dynamic interaction networks.

Each approach AP-MS, proximity labeling, XL-MS, and co-fractionation offers complementary insights. When combined with quantitative proteomics and computational analysis, these methods provide a powerful framework for understanding cellular biology and disease mechanisms.

As technologies continue to evolve, MS-based interactomics will play a central role in precision medicine, drug discovery, and systems biology.